Healthpeak Properties, Inc. (DOC)
| Market Cap | 13.80B +4.8% |
| Revenue (ttm) | 2.87B +2.7% |
| Net Income | 221.63M -20.5% |
| EPS | 0.32 -19.7% |
| Shares Out | 702.42M |
| PE Ratio | 61.59 |
| Forward PE | 86.10 |
| Dividend | $1.22 (6.21%) |
| Ex-Dividend Date | May 18, 2026 |
| Volume | 7,229,218 |
| Open | 19.69 |
| Previous Close | 19.66 |
| Day's Range | 19.35 - 19.87 |
| 52-Week Range | 15.70 - 19.87 |
| Beta | 0.98 |
| Analysts | Hold |
| Price Target | 18.54 (-5.6%) |
| Earnings Date | May 5, 2026 |
About DOC
Healthpeak Properties, Inc. is a Standard & Poor’s 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered... [Read more]
Financial Performance
In 2025, Healthpeak Properties's revenue was $2.82 billion, an increase of 4.52% compared to the previous year's $2.70 billion. Earnings were $70.51 million, a decrease of -70.91%.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for DOC stock is "Hold." The 12-month stock price target is $18.54, which is a decrease of -5.60% from the latest price.
News
Healthpeak Properties Earnings Call Transcript: Q1 2026
Q1 2026 saw strong execution with the Janus Living IPO, robust leasing in all segments, and accretive capital actions. Guidance was raised as senior housing and outpatient medical outperformed, while life science occupancy and pipeline improved.
Healthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 Results
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the quarter...
Healthpeak Properties Transcript: AGM 2026
The meeting established a quorum and proceeded with three business items, resulting in the election of all director nominees and approval of two proposals. No shareholder questions were raised, and final results will be filed with the SEC.
Healthpeak Properties price target lowered to $18 from $21 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Healthpeak Properties (DOC) to $18 from $21 and keeps an Overweight rating on the shares after updating the firm’s 2026 and 2027
Healthpeak Properties initiated with a Neutral at UBS
UBS initiated coverage of Healthpeak Properties (DOC) with a Neutral rating and $17 price target The stable performance in outpatient medical and senior housing is being offset by ongoing weakness
Healthpeak Properties initiated with a Neutral at UBS
UBS initiated coverage of Healthpeak Properties (DOC) with a Neutral rating and $17 price target The stable performance in outpatient medical and senior housing is being offset by ongoing weakness
Janus Living initiated with a Buy at BofA
BofA initiated coverage of Janus Living (JAN) with a Buy rating and $29 price target. The pure-play senior housing REIT externally managed by Healthpeak Properties (DOC) has 100% NOI exposure
Healthpeak Properties Announces Dates of First Quarter 2026 Earnings Release, Conference Call, and Webcast
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report first quarter 20...
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on April 6, 2026, its Bo...
Healthpeak Properties price target lowered to $19 from $20 at Baird
Baird analyst Wesley Golladay lowered the firm’s price target on Healthpeak Properties (DOC) to $19 from $20 and keeps an Outperform rating on the shares. The firm updated its model
Citi cuts Healthpeak target, opens ‘upside 30-day catalyst watch’
Citi lowered the firm’s price target on Healthpeak Properties (DOC) to $17.50 from $18 and keeps a Neutral rating on the shares. Citi also opened an “upside 30-day catalyst watch”
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambrid...
Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that it ...
Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial public o...
5 ‘Healthy' Dividends Paying Up To 14.1%
Healthcare dividend stocks are selling off with the turbulence in the Middle East.
Janus Living indicated to open at $23-$24, IPO priced at $20 per share
Healthpeak Properties (DOC) and Janus Living (JAN) announced the pricing of Janus Living’s upsized initial public offering of 42M shares of Janus Living Class A-1 common stock at a price
Healthpeak Properties and Janus Living Announce Pricing of Upsized $840 Million Janus Living Initial Public Offering
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (“Janus Living”) announced the pricing of Janus Living's upsized initial public offering (“IPO”) ...
Janus Living to price 37M shares between $18.00-$20.00 in IPO
Healthpeak Properties (DOC) and Janus Living announced that Janus Living has launched its initial public offering of 37,000,000 shares of its Class A-1 common stock pursuant to a registration statemen...
Healthpeak Properties and Janus Living Announce Launch of Janus Living Initial Public Offering
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (“Janus Living”), announced today that Janus Living has launched its initial public offering of 3...
Healthpeak Properties Transcript: Citi’s Miami Global Property CEO Conference 2026
Healthpeak highlighted successful merger integration, internalized management, and the upcoming Janus Living IPO to unlock senior housing value. Strong market fundamentals in life science and outpatient medical segments support capital recycling and growth, while technology and AI adoption drive operational efficiency.
Healthpeak Properties: Janus Living files registration statement on Form S-11
Healthpeak Properties (DOC) announced that Janus Living has publicly filed a registration statement on Form S-11 with the SEC relating to a proposed initial public offering of its shares of
Healthpeak Properties, Inc. Announces Public Filing of Registration Statement with the SEC for Janus Living, Inc.
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) today announced that Janus Living, Inc., a pure-play senior housing real estate investment trust (“REIT”), has publicly filed a registr...
Healthpeak Properties downgraded to Hold from Buy at Argus
Argus analyst Marie Ferguson downgraded Healthpeak Properties (DOC) to Hold from Buy.
Healthpeak Properties Earnings Call Transcript: Q4 2025
Earnings for 2025 met guidance, with strong Outpatient Medical and Senior Housing performance offsetting lab headwinds. 2026 guidance reflects lab occupancy challenges, but growth is expected in 2027 as sector fundamentals improve and capital recycling continues.
Healthpeak Properties price target lowered to $18 from $19 at Wells Fargo
Wells Fargo analyst John Kilichowski lowered the firm’s price target on Healthpeak Properties (DOC) to $18 from $19 and keeps an Equal Weight rating on the shares. The firm recently